Transgenerational cardiology: One way to a baby's heart is through the mother
| Autor: | Rachel A. Magnan, Suk D. Regmi, M. Rebecca Zhang, Ehiole Akhirome, Julie M. Nogee, Yidan Qin, James M. Cheverud, Patrick Y. Jay, Nelson Ugwu, Lillian Kang |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Heart Defects
Congenital 0301 basic medicine Heart disease Offspring Biology Bioinformatics Polymorphism Single Nucleotide Biochemistry Article Mice 03 medical and health sciences Endocrinology Transgenerational epigenetics Pregnancy Risk Factors Genetic variation medicine Animals Humans Genetic Predisposition to Disease Young adult Exercise Molecular Biology Genetics Human studies medicine.disease Pregnancy Complications Clinical trial Disease Models Animal 030104 developmental biology Female Maternal Age |
| Zdroj: | Molecular and Cellular Endocrinology. 435:94-102 |
| ISSN: | 0303-7207 |
| DOI: | 10.1016/j.mce.2016.08.029 |
| Popis: | Despite decades of progress, congenital heart disease remains a major cause of mortality and suffering in children and young adults. Prevention would be ideal, but formidable biological and technical hurdles face any intervention that seeks to target the main causes, genetic mutations in the embryo. Other factors, however, significantly modify the total risk in individuals who carry mutations. Investigation of these factors could lead to an alternative approach to prevention. To define the risk modifiers, our group has taken an "experimental epidemiologic" approach via inbred mouse strain crosses. The original intent was to map genes that modify an individual's risk of heart defects caused by an Nkx2-5 mutation. During the analysis of >2000 Nkx2-5(+/-) offspring from one cross we serendipitously discovered a maternal-age associated risk, which also exists in humans. Reciprocal ovarian transplants between young and old mothers indicate that the incidence of heart defects correlates with the age of the mother and not the oocyte, which implicates a maternal pathway as the basis of the risk. The quantitative risk varies between strain backgrounds, so maternal genetic polymorphisms determine the activity of a factor or factors in the pathway. Most strikingly, voluntary exercise by the mother mitigates the risk. Therefore, congenital heart disease can in principle be prevented by targeting a maternal pathway even if the embryo carries a causative mutation. Further mechanistic insight is necessary to develop an intervention that could be implemented on a broad scale, but the physiology of maternal-fetal interactions, aging, and exercise are notoriously complex and undefined. This suggests that an unbiased genetic approach would most efficiently lead to the relevant pathway. A genetic foundation would lay the groundwork for human studies and clinical trials. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect